Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6890928rdf:typepubmed:Citationlld:pubmed
pubmed-article:6890928lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:6890928lifeskim:mentionsumls-concept:C0678828lld:lifeskim
pubmed-article:6890928lifeskim:mentionsumls-concept:C0008286lld:lifeskim
pubmed-article:6890928lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6890928lifeskim:mentionsumls-concept:C0683370lld:lifeskim
pubmed-article:6890928lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:6890928pubmed:issue2lld:pubmed
pubmed-article:6890928pubmed:dateCreated1983-2-25lld:pubmed
pubmed-article:6890928pubmed:abstractTextIn rats given methamphetamine (MAPT, 10 mg/kg i.p.) 24 hrs--48 hrs after the long term-administration of reserpine (RE), we have previously found such "bizarre-biting behaviour" as persistent and bloody biting activity at their own legs and tails or those of their cage mates. The present investigation examined the effect of a blockade of the dopamine receptor in the brain on MAPT-induced "bizarre-biting behaviour" and hypermotility of RE-pretreated rats. Male albino Wistar rats aged 4 weeks were injected intraperitoneally with RE (1.25 mg/kg) or 0.9% saline solution (1.25 ml/kg) every two days for 13 days. Twenty-three hrs after the last injection, rats received chlorpromazine (CP, 150 micrograms, 250 micrograms, 625 micrograms, or 1 mg/rat) intracerebrally by Valzelli's method; and 1 hr later, MAPT (10 mg/kg i.p.) was injected. MAPT-induced hypermotility was potentiated in the RE-pretreated rats, but it was suppressed dose-dependently by CP. Stereotyped licking and biting activities of saline-pretreated rats were completely suppressed by CP at each dose given, however, the "bizarre-biting behaviour" of RE-pretreated rats was inhibited by CP only at high doses (625 micrograms or 1 mg/rat). It is suggested that the MAPT-induced hypermotility of RE-pretreated rats is mediated by activation of dopamine receptor while their "bizarre-biting behaviour" is partially related to it.lld:pubmed
pubmed-article:6890928pubmed:languagejpnlld:pubmed
pubmed-article:6890928pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6890928pubmed:citationSubsetIMlld:pubmed
pubmed-article:6890928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6890928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6890928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6890928pubmed:statusMEDLINElld:pubmed
pubmed-article:6890928pubmed:monthAuglld:pubmed
pubmed-article:6890928pubmed:issn0015-5691lld:pubmed
pubmed-article:6890928pubmed:authorpubmed-author:KobayashiMMlld:pubmed
pubmed-article:6890928pubmed:authorpubmed-author:SakaiKKlld:pubmed
pubmed-article:6890928pubmed:authorpubmed-author:SanoHHlld:pubmed
pubmed-article:6890928pubmed:authorpubmed-author:KoshikawaNNlld:pubmed
pubmed-article:6890928pubmed:authorpubmed-author:TotsukaYYlld:pubmed
pubmed-article:6890928pubmed:authorpubmed-author:FuruuchiTTlld:pubmed
pubmed-article:6890928pubmed:authorpubmed-author:ShigeharaRRlld:pubmed
pubmed-article:6890928pubmed:issnTypePrintlld:pubmed
pubmed-article:6890928pubmed:volume80lld:pubmed
pubmed-article:6890928pubmed:ownerNLMlld:pubmed
pubmed-article:6890928pubmed:authorsCompleteYlld:pubmed
pubmed-article:6890928pubmed:pagination113-24lld:pubmed
pubmed-article:6890928pubmed:dateRevised2011-7-27lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:meshHeadingpubmed-meshheading:6890928-...lld:pubmed
pubmed-article:6890928pubmed:year1982lld:pubmed
pubmed-article:6890928pubmed:articleTitle["Methamphetamine-stereotypy and hypermotility" in rats chronically treated with reserpine--the effect of intracerebral injection of chlorpromazine].lld:pubmed
pubmed-article:6890928pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6890928pubmed:publicationTypeEnglish Abstractlld:pubmed